Skip to main content
Egyptian Liver Journal

Table 3 Overall survival (OS) in low- and high-risk patients according to the AFP model

From: Risk stratification of patients with hepatocellular carcinoma undergoing trans arterial chemoembolization using an alpha-fetoprotein model

Risk level

OS (months)

95% CI

P value

Sig.

Survival (%) at

Median

SE

Lower

Upper

1 year

3 years

Low-risk

32

4.441

23.295

40.705

> 0.05

NS

97.00%

37.30%

High-risk

29

6.169

16.908

41.092

98.1%

11.6%

  1. OS, Overall survival, NS nonsignificant, CI Confidence interval
Back to article page